Eleftheria Maratos-Flier

Title: Eleftheria Maratos-Flier: Innovator in Metabolic Research

Introduction

Eleftheria Maratos-Flier is a prominent inventor based in Newton, MA (US). She has made significant contributions to the field of metabolic research, holding a total of four patents. Her work focuses on understanding and improving metabolic processes, particularly in relation to fructose metabolism and pancreatic function.

Latest Patents

One of her latest patents is titled "Measurement of FGF21 as a biomarker of fructose metabolism." This invention provides methods for monitoring the fructose response of a subject by determining the level of fibroblast growth factor 21 (FGF21) gene expression product in a biological sample, such as serum. The invention also includes methods for monitoring a subject's response to treatment for metabolic disorders, discriminating fructose intolerance from other gastrointestinal disorders, and identifying individuals at risk for developing metabolic disorders. Another notable patent is focused on "Methods of modulating β cell function," which involves modulating pancreatic function by influencing MCH signaling in β cells.

Career Highlights

Throughout her career, Eleftheria has worked with esteemed institutions such as the Joslin Diabetes Center and Beth Israel Deaconess Medical Center. Her research has been pivotal in advancing our understanding of metabolic diseases and potential treatments.

Collaborations

Eleftheria has collaborated with notable colleagues, including Rohit N Kulkarni and Pavlos Pissios, contributing to a rich exchange of ideas and research in the field of diabetes and metabolism.

Conclusion

Eleftheria Maratos-Flier's innovative work in metabolic research has led to significant advancements in understanding fructose metabolism and pancreatic function. Her contributions continue to impact the field and pave the way for future research and treatments.